Cargando…
Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
COVID-19, which was first reported in December 2019 in China, has caused a global outbreak. Five variants of concern (VOCs) have been identified in different countries since the global pandemic, namely, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.529). Although m...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041375/ https://www.ncbi.nlm.nih.gov/pubmed/35492429 http://dx.doi.org/10.2217/fvl-2021-0100 |
_version_ | 1784694533209980928 |
---|---|
author | Zhang, Meng Gong, Yixin Jiao, Shunchang |
author_facet | Zhang, Meng Gong, Yixin Jiao, Shunchang |
author_sort | Zhang, Meng |
collection | PubMed |
description | COVID-19, which was first reported in December 2019 in China, has caused a global outbreak. Five variants of concern (VOCs) have been identified in different countries since the global pandemic, namely, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.529). Although multiple vaccines have been found to be effective, some of the amino acid changes may increase the infectivity of virus and decrease the sensitivity to antibodies. Here we characterize the VOCs and discuss their sensitivity to antibodies elicited by convalescent and vaccinee sera. In conclusion, several variants display a reduction in the susceptibility to neutralization antibodies generated by natural infection or vaccination, which threatens the containment of the epidemic. |
format | Online Article Text |
id | pubmed-9041375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-90413752022-04-27 Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent Zhang, Meng Gong, Yixin Jiao, Shunchang Future Virol Review COVID-19, which was first reported in December 2019 in China, has caused a global outbreak. Five variants of concern (VOCs) have been identified in different countries since the global pandemic, namely, Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.529). Although multiple vaccines have been found to be effective, some of the amino acid changes may increase the infectivity of virus and decrease the sensitivity to antibodies. Here we characterize the VOCs and discuss their sensitivity to antibodies elicited by convalescent and vaccinee sera. In conclusion, several variants display a reduction in the susceptibility to neutralization antibodies generated by natural infection or vaccination, which threatens the containment of the epidemic. Future Medicine Ltd 2022-04-26 2022-03 /pmc/articles/PMC9041375/ /pubmed/35492429 http://dx.doi.org/10.2217/fvl-2021-0100 Text en © 2022 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Review Zhang, Meng Gong, Yixin Jiao, Shunchang Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
title | Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
title_full | Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
title_fullStr | Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
title_full_unstemmed | Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
title_short | Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
title_sort | neutralization heterogeneity of circulating sars-cov-2 variants to sera elicited by a vaccinee or convalescent |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041375/ https://www.ncbi.nlm.nih.gov/pubmed/35492429 http://dx.doi.org/10.2217/fvl-2021-0100 |
work_keys_str_mv | AT zhangmeng neutralizationheterogeneityofcirculatingsarscov2variantstoseraelicitedbyavaccineeorconvalescent AT gongyixin neutralizationheterogeneityofcirculatingsarscov2variantstoseraelicitedbyavaccineeorconvalescent AT jiaoshunchang neutralizationheterogeneityofcirculatingsarscov2variantstoseraelicitedbyavaccineeorconvalescent |